CMS vs. CRSP
CMS (CMS Energy Corporation) and CRSP (CRISPR Therapeutics AG) are both stocks. CMS operates in Utilities - Regulated Electric (Utilities), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, CMS returned 8.16%/yr vs -16.09%/yr for CRSP. At a 0.03 correlation, their price movements are largely independent.
Performance
CMS vs. CRSP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CMS achieves a 7.15% return, which is significantly higher than CRSP's 3.66% return.
CMS
- 1D
- 0.57%
- 1M
- -0.98%
- YTD
- 7.15%
- 6M
- 7.40%
- 1Y
- 10.14%
- 3Y*
- 11.48%
- 5Y*
- 8.16%
- 10Y*
- 8.46%
CRSP
- 1D
- 0.50%
- 1M
- 7.94%
- YTD
- 3.66%
- 6M
- -6.13%
- 1Y
- 22.85%
- 3Y*
- -1.00%
- 5Y*
- -16.09%
- 10Y*
- —
CMS vs. CRSP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CMS CMS Energy Corporation | 7.15% | 8.13% | 18.60% | -5.21% | 0.84% | 9.71% | -0.32% | 30.04% | 8.25% | 17.03% |
CRSP CRISPR Therapeutics AG | 3.66% | 33.23% | -37.12% | 54.00% | -46.36% | -50.51% | 151.39% | 113.18% | 21.68% | 15.89% |
Correlation
The correlation between CMS and CRSP is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2016 | 0.03 |
Fundamentals
CMS:
$4.92
CRSP:
-$6.24
CMS:
1.88
CRSP:
1.21K
CMS:
$8.82B
CRSP:
$4.10M
CMS:
$4.16B
CRSP:
-$171.17M
CMS:
$3.09B
CRSP:
-$509.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CMS vs. CRSP — Risk / Return Rank
CMS
CRSP
CMS vs. CRSP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CMS Energy Corporation (CMS) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CMS | CRSP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.26 | ||
| Sortino ratioReturn per unit of downside risk | -0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.11 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 0.89 | 0.54 | +0.34 |
| Martin ratioReturn relative to average drawdown | 2.25 | 0.89 | +1.37 |
Loading charts...
Drawdowns
CMS vs. CRSP - Drawdown Comparison
The maximum CMS drawdown since its inception was -91.20%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for CMS and CRSP.
Loading charts...
Drawdown Indicators
| CMS | CRSP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.20% | -85.11% | -6.09% |
Max Drawdown (1Y)Largest decline over 1 year | -11.48% | -42.25% | +30.77% |
Max Drawdown (3Y)Largest decline over 3 years | -19.61% | -64.91% | +45.30% |
Max Drawdown (5Y)Largest decline over 5 years | -27.56% | -80.68% | +53.12% |
Max Drawdown (10Y)Largest decline over 10 years | -29.55% | — | — |
Current DrawdownCurrent decline from peak | -6.96% | -74.12% | +67.16% |
Average DrawdownAverage peak-to-trough decline | -27.33% | -49.29% | +21.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.51% | 25.88% | -21.37% |
Volatility
CMS vs. CRSP - Volatility Comparison
The current volatility for CMS Energy Corporation (CMS) is 6.46%, while CRISPR Therapeutics AG (CRSP) has a volatility of 17.92%. This indicates that CMS experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CMS | CRSP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.46% | 17.92% | -11.46% |
Volatility (6M)Calculated over the trailing 6-month period | 12.45% | 43.95% | -31.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.22% | 62.70% | -46.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.93% | 60.72% | -41.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.72% | 64.31% | -43.59% |
Dividends
CMS vs. CRSP - Dividend Comparison
CMS's dividend yield for the trailing twelve months is around 3.01%, while CRSP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMS CMS Energy Corporation | 3.01% | 3.10% | 3.09% | 3.36% | 3.62% | 2.67% | 2.67% | 2.43% | 2.88% | 2.81% | 2.98% | 3.22% |
CRSP CRISPR Therapeutics AG | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CMS vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between CMS Energy Corporation and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CMS and CRSP have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRSP has higher volatility (17.92%) compared to CMS (6.46%). In terms of maximum drawdown, CMS dropped -91.20% vs CRSP's -85.11%.
CMS currently has the higher Sharpe Ratio (0.63 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CMS and CRSP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer